CCL16 binds to chemokine receptors (CCR1, CCR5, and CCR8) to activate angiogenesis in vascular endothelium and is related with prognosis in breast cancer and lung cancer [39, 40]. The gene discussed is CCR8; the disease is lung carcinoma.